Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.110
-0.140 (-3.29%)
At close: Jun 27, 2025, 4:00 PM
4.140
+0.030 (0.73%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $127.35 million as of June 27, 2025. Its market cap has decreased by -55.64% in one year.
Market Cap
127.35M
Enterprise Value
68.53M
1-Year Change
-55.64%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $127.35M, a decrease of -64.24%. That is a compound annual growth rate of -57.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 127.30M | 48.20% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 716.12B |
| Johnson & Johnson | 366.16B |
| AbbVie | 329.91B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 276.45B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.93B |
| AstraZeneca | 215.99B |